Objective: Current teaching is to avoid placing fistulas on the same side as a pacemaker, but no studies have quantified whether patients with ipsilateral fistulas have higher rates of intervention than those with contralateral access. This study aimed to compare secondary intervention rates in end-stage renal disease patients with pacemakers placed on the ipsilateral vs contralateral side of arteriovenous access.
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Comparison of Secondary Intervention
Methods: All patients >18 years old who had a fistula or graft placed on the side ipsilateral or contralateral to a pacemaker were included. Data were collected retrospectively from a prospectively collected, single-institution database from 2008 to 2017. Data points included demographics; number of secondary interventions, specifically thrombectomy, percutaneous transluminal angioplasty (PTA), and stent placement; time to first intervention; and failure of the fistula or graft. Statistical analysis was performed by descriptive statistics and Fisher exact test.
Results: During the 9-year study period, 32 patients were identified who had a pacemaker and arteriovenous access. Twenty patients had contralateral placement. The average age of this cohort was 67 years (range, 44-83 years). The majority of the group was Hispanic (nine [45%]), followed by white (six [30%]) and Asian (five [25%]); 50% (10) of patients underwent a secondary intervention: 50% (10) had PTA and 20% (2) had stents placed. There were 36 PTAs performed in 10 patients with an average of 3.6 PTAs per patient (range, 1-12). The average time to first PTA was 19.5 months (range, 2-44 months). Twelve patients had ipsilateral placement. The average age of this group was 69 years (range, 59-85 years). The majority of the group was Hispanic (seven [59%]), followed by white (four [33%]) and Asian (one [8%]); 75% (nine) of patients underwent a secondary intervention: 75% (nine) had PTA and 33% (three) had stents placed. There were 25 PTAs performed in nine patients with an average of 2.8 PTAs per patient (range, 1-6). The average time to first PTA was 9.5 months (range, 1-27 months). There was no difference in intervention rates between ipsilateral and contralateral patients; however, the time to intervention was significantly increased in patients who had arteriovenous access on the side contralateral to their pacemaker (9.5 months vs 19.5 months).
Conclusions: This study indicates that rates of secondary intervention are similar regardless of whether arteriovenous access is placed on the side ipsilateral or contralateral to a pacemaker. However, the time to first intervention is significantly increased in patients who have contralateral placement.
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IP147. A Novel Technique to Increase the Maturation Rate of Arteriovenous Fistulas
Courtney Grant, Elias Kfoury, Dipankar Mukherjee, Homayoun Hashemi. Inova Fairfax Hospital, Vienna, Va
Objective: Given the superior patency of arteriovenous (AV) fistulas and the decreased risk of infection compared with arteriovenous grafts, the Kidney Disease Outcomes Quality Initiative guidelines recommend the Fistula First approach. Unfortunately, about 18% to 53% of all fistulas fail to mature. Our objective was to describe and to review a novel technique using bovine pericardial patch angioplasty that can increase the rate of AV fistula maturation.
Methods: A retrospective review was conducted of patients who underwent bovine pericardial patch angioplasty for AV fistulas that failed to mature. Procedures were performed by a single surgeon from March 2007 to December 2015. Medical records were reviewed for each patient. Data were collected on patients' demographics, operative details, current fistula function, and fistula follow-up assessments.
Results: Patch angioplasty was performed on 110 patients with nonmaturing fistulas. Ninety-five patients whose fistula status was able to be determined were included in the analysis. A total of 86 (90.5%) fistulas matured to be used for hemodialysis, and 80 were actually accessed. At 1 year, 64 (80%) of these accessed mature fistulas remained patent and 4 (4.7%) thrombosed. The remaining 20.9% died or were lost to follow-up. Of the mature fistulas still patent at 1 year, 23 patients (35.9%) required intervention because of stenosis proximal or distal to the patch with an 8-month average time to reintervention. Complications included three (3.2%) thromboses within the first month, four
